Related Experiment Video
Updated: Dec 7, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
The use of hydroxocobalamin for vasoplegic syndrome in left ventricular assist device patients
Brian Ayers1, Katherine Wood1, Jennifer Falvey2
1Division of Cardiac Surgery University of Rochester Medical Center Rochester NY USA.
Abstract:
We demonstrate evidence supporting the efficacy of hydroxocobalamin in reducing vasopressor requirements for LVAD patients with refractory vasoplegia. Further study is needed to substantiate these findings and determine its optimal use in practice.
More Related Videos
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Cardiomyopathy V: Interprofessional Care
Hemodialysis II: Procedure and Complications
Cardiac Catheterization IV: Nursing Management
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Heart Failure Drugs: Inotropic Agents

